Skip to main content

World's First Real-Time Monitoring System for Ablation Procedures

Project description

Real-time monitoring during the ablation procedure

Ablation therapy is a minimally invasive procedure used to destroy abnormal tissue in many conditions, including for cancer tumour removal, and it could be the best alternative to surgery. However, its application is still limited due to high unpredictability in relation to the extent of the lesion during the intervention. Techsomed medical technologies is developing a device for monitoring in real time the extent of the lesion during the ablation procedure and to predict the outcome 24 hours post-treatment. Tracking the tissue's biological response to the heat using an AI-based algorithm will enable monitoring during ablation to alert medical personnel when damage is observed outside the surgical margin. The EU-funded BioTrace project will support the feasibility study to assess the technical, commercial and financial parameters of the project.

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

TECHSOMED MEDICAL TECHNOLOGIES LTD
Address
Meir Weisgal 2 St., Science Park
7632605 Rehovot
Israel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000